Skip to main content
Top
Published in:

16-03-2023 | Sleep-Related Breathing Disorders | Sleep Breathing Physiology and Disorders • Review

Kidney transplantation: a possible solution to obstructive sleep apnea in patients with end-stage kidney disease

Authors: Mehmet Kanbay, Carina Ureche, Sidar Copur, Alexandra M. Covic, Cem Tanriover, Bugra H. Esen, Mert Sekmen, Asiye Kanbay, Adrian Covic

Published in: Sleep and Breathing | Issue 5/2023

Login to get access

Abstract

Introduction

Obstructive sleep apnea (OSA) is frequently reported among patients with chronic kidney disease resulting in considerable morbidity and mortality. OSA may cause repetitive stimulation of the sympathetic nervous system and elevations in pulmonary artery pressure leading to an elevated risk of cardiac and vascular complications in patients with chronic kidney disease. Furthermore, OSA is associated with progressive worsening of kidney injury and loss of renal function.

Methods

In this systematic review and meta-analysis, we evaluated the effect of renal transplantation on the progression of OSA in patients with end-stage kidney disease.

Results

The meta-analysis included eight studies with a total of 401 patients. Findings showed that kidney transplantation does not lead to a statistically significant effect on the apnea–hypopnea index (MD 2.6 events/hr, 95% CI −3.2 to 8.3, p = 0.21), total sleep time (MD 14.7 min/night, 95% CI −8.4 to 37.8, p = 0.76), sleep efficiency (MD 2.5%, 95% CI −1.4 to 6.3, p = 0.57), slow wave sleep (MD 0.4% of total sleep time, 95% CI −7.5 to 8.4, p = 0.05), and rapid eye movement sleep (MD 0.6% of total sleep time, 95% CI −2.2 to 3.3, p = 0.98). There was no statistically significant effect of kidney transplantation on OSA in patients with chronic renal disease.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Kidney transplantation: a possible solution to obstructive sleep apnea in patients with end-stage kidney disease
Authors
Mehmet Kanbay
Carina Ureche
Sidar Copur
Alexandra M. Covic
Cem Tanriover
Bugra H. Esen
Mert Sekmen
Asiye Kanbay
Adrian Covic
Publication date
16-03-2023

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Watch the full video

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Log in / Register to watch the full video

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025: the 85th Scientific Sessions

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s annual meeting.

Read more